Literature DB >> 19660381

Reliability of positron emission tomography-computed tomography in identification of mediastinal lymph node status in patients with non-small cell lung cancer.

Maruf Sanli1, Ahmet Feridun Isik, Sabri Zincirkeser, Osman Elbek, Ahmet Mete, Bulent Tuncozgur, Levent Elbeyli.   

Abstract

OBJECTIVE: The involvement of mediastinal lymph nodes is a very important prognostic factor in patients with potentially resectable non-small cell lung cancer. Our aim in this study was to investigate the value of positron emission tomographic-computed tomographic scanning in staging lung cancer, especially for mediastinal lymph node evaluation, and to determine whether this could decrease the need for mediastinoscopy.
METHODS: Seventy-eight patients with non-small cell lung cancer who were potential candidates for surgical resection and admitted to the thoracic surgery unit of our hospital from March 2006 to June 2008 joined this prospective study. Positron emission tomographic-computed tomographic scanning was performed as part of the prospective studies used to diagnose or stage the tumors. All 78 patients underwent tissue sampling of mediastinal lymph nodes to compare these with imaging results. The diagnostic efficacy of the computed tomographic and positron emission tomographic-computed tomographic scans compared with histopathologic findings were calculated with sensitivity, specificity, positive and negative predictive values, and accuracy.
RESULTS: Final histology was available on 397 lymph node stations (N1, N2, and N3) sampled from 78 patients during mediastinoscopy or surgical intervention. Sensitivity, specificity, and positive and negative predictive values of mediastinal lymph node involvement in patients undergoing thoracic computed tomographic scanning were 45.4%, 80.5%, 27.7%, and 90%, respectively. The accuracy of computed tomographic scanning was 75.6%. The sensitivity, specificity, and positive and negative predictive values of mediastinal lymph node involvement in patients undergoing positron emission tomographic-computed tomographic scanning were 81.8%, 89.5%, 56.2%, and 96.7%, respectively.
CONCLUSION: There is a need for mediastinoscopy in positron emission tomographic-computed tomographic scanning-positive mediastinal lymph nodes, but it might not be necessary for positron emission tomographic-computed tomographic scanning-negative lymph nodes.

Entities:  

Mesh:

Year:  2009        PMID: 19660381     DOI: 10.1016/j.jtcvs.2009.03.035

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  9 in total

1.  Can lymph node evaluation be performed well by video-assisted thoracic surgery?

Authors:  Zhenrong Zhang; Hongxiang Feng; Xiaowei Wang; Chaoyang Liang; Deruo Liu
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-02       Impact factor: 4.553

2.  Variations in positron emission tomography-computed tomography findings for patients receiving neoadjuvant and non-neoadjuvant therapy for non-small cell lung cancer.

Authors:  Jae Kil Park; Jae Jun Kim; Seok Whan Moon
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

3.  Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer.

Authors:  Yoichi Ohtaki; Kimihiro Shimizu; Kyoichi Kaira; Toshiteru Nagashima; Kai Obayashi; Seshiru Nakazawa; Seiichi Kakegawa; Hitoshi Igai; Mitsuhiro Kamiyoshihara; Masahiko Nishiyama; Izumi Takeyoshi
Journal:  Surg Today       Date:  2016-01-19       Impact factor: 2.549

Review 4.  Staging lymph node metastases from lung cancer in the mediastinum.

Authors:  Mario D Terán; Malcolm V Brock
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

5.  Endobronchial ultrasound: morphological predictors of benign disease.

Authors:  Pratibha Gogia; Tabassum Z Insaf; William McNulty; Afroditi Boutou; Andrew G Nicholson; Zaid Zoumot; Pallav L Shah
Journal:  ERJ Open Res       Date:  2016-01-20

6.  Texture Analysis and Synthesis of Malignant and Benign Mediastinal Lymph Nodes in Patients with Lung Cancer on Computed Tomography.

Authors:  Tuan D Pham; Yuzuru Watanabe; Mitsunori Higuchi; Hiroyuki Suzuki
Journal:  Sci Rep       Date:  2017-02-24       Impact factor: 4.379

7.  The Role of Fluorodeoxy-D-glucose Positron Emission Tomography/Computed Tomography in Nodal Staging of Nonsmall Cell Lung Cancer in Sequential Surgical Algorithm.

Authors:  Yuyang Zhang; Yolanda Elam; Patricia Hall; Hadyn Williams; Darko Pucar; Vijay Patel
Journal:  World J Nucl Med       Date:  2017 Oct-Dec

8.  Prognostic factors in operated T3 non-small cell lung cancer: A retrospective, single-center study of 129 patients.

Authors:  Ahmet Uluşan; Maruf Şanlı; Ahmet Feridun Işık; Miray Ersöz; Bülent Tunçözgür; Kemal Bakır; Seval Kul; Levent Elbeyli
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-01-09       Impact factor: 0.332

9.  A pilot study of 4'-[methyl-11C]-thiothymidine PET/CT for detection of regional lymph node metastasis in non-small cell lung cancer.

Authors:  Ryogo Minamimoto; Jun Toyohara; Hideyuki Ito; Ayako Seike; Yoko Miyata; Miyako Morooka; Momoko Okasaki; Kazuhiko Nakajima; Kimiteru Ito; Kiichi Ishiwata; Kazuo Kubota
Journal:  EJNMMI Res       Date:  2014-03-05       Impact factor: 3.138

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.